pharmaceutical mergers
Media
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
Billionairesworld's billionaires
Stefano Pessina: The Visionary Behind the Global Pharmaceutical Giant | Richest person in Monaco
Stefano Pessina, a name that has become synonymous with the global pharmaceutical industry, is a man whose strategic vision and leadership have transformed...
